Josserand V - Search Results

1

Electrochemotherapy guided by intraoperative fluorescence imaging for the treatment of inoperable peritoneal micro-metastases.

Josserand V, Kéramidas M, Lavaud J, Righini C, Vollaire J, Bellard E, Rols MP, Teissié J, Coll JL, Golzio M. Josserand V, et al. J Control Release. 2016 Jul 10;233:81-7. doi: 10.1016/j.jconrel.2016.05.003. Epub 2016 May 4. J Control Release. 2016. PMID: 27155365

2

Activatable fluorescent probes for tumour-targeting imaging in live mice.

Razkin J, Josserand V, Boturyn D, Jin ZH, Dumy P, Favrot M, Coll JL, Texier I. Razkin J, et al. Among authors: josserand v. ChemMedChem. 2006 Oct;1(10):1069-72. doi: 10.1002/cmdc.200600118. ChemMedChem. 2006. PMID: 16944544 No abstract available.

3

Noninvasive optical imaging of ovarian metastases using Cy5-labeled RAFT-c(-RGDfK-)4.

Jin ZH, Josserand V, Razkin J, Garanger E, Boturyn D, Favrot MC, Dumy P, Coll JL. Jin ZH, et al. Among authors: josserand v. Mol Imaging. 2006 Jul;5(3):188-97. Mol Imaging. 2006. PMID: 16954034

4

In vivo noninvasive optical imaging of receptor-mediated RGD internalization using self-quenched Cy5-labeled RAFT-c(-RGDfK-)(4).

Jin ZH, Razkin J, Josserand V, Boturyn D, Grichine A, Texier I, Favrot MC, Dumy P, Coll JL. Jin ZH, et al. Among authors: josserand v. Mol Imaging. 2007 Jan-Feb;6(1):43-55. Mol Imaging. 2007. PMID: 17311764

5

In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors.

Jin ZH, Josserand V, Foillard S, Boturyn D, Dumy P, Favrot MC, Coll JL. Jin ZH, et al. Among authors: josserand v. Mol Cancer. 2007 Jun 12;6:41. doi: 10.1186/1476-4598-6-41. Mol Cancer. 2007. PMID: 17565663 Free PMC article.

6

Non-invasive in vivo optical imaging of the lacZ and luc gene expression in mice.

Josserand V, Texier-Nogues I, Huber P, Favrot MC, Coll JL. Josserand V, et al. Gene Ther. 2007 Nov;14(22):1587-93. doi: 10.1038/sj.gt.3303028. Epub 2007 Sep 20. Gene Ther. 2007. PMID: 17882264

7

In vivo mice lung tumor follow-up with fluorescence diffuse optical tomography.

Koenig A, Hervé L, Josserand V, Berger M, Boutet J, Da Silva A, Dinten JM, Peltié P, Coll JL, Rizo P. Koenig A, et al. Among authors: josserand v. J Biomed Opt. 2008 Jan-Feb;13(1):011008. doi: 10.1117/1.2884505. J Biomed Opt. 2008. PMID: 18315357 Free article.

8

Small-molecule drugs mimicking DNA damage: a new strategy for sensitizing tumors to radiotherapy.

Quanz M, Berthault N, Roulin C, Roy M, Herbette A, Agrario C, Alberti C, Josserand V, Coll JL, Sastre-Garau X, Cosset JM, Larue L, Sun JS, Dutreix M. Quanz M, et al. Among authors: josserand v. Clin Cancer Res. 2009 Feb 15;15(4):1308-16. doi: 10.1158/1078-0432.CCR-08-2108. Epub 2009 Feb 3. Clin Cancer Res. 2009. PMID: 19190126

9

Drug development in oncology assisted by noninvasive optical imaging.

Sancey L, Dufort S, Josserand V, Keramidas M, Righini C, Rome C, Faure AC, Foillard S, Roux S, Boturyn D, Tillement O, Koenig A, Boutet J, Rizo P, Dumy P, Coll JL. Sancey L, et al. Among authors: josserand v. Int J Pharm. 2009 Sep 11;379(2):309-16. doi: 10.1016/j.ijpharm.2009.05.034. Epub 2009 May 23. Int J Pharm. 2009. PMID: 19467306 Free article.

10

The cell line secretome, a suitable tool for investigating proteins released in vivo by tumors: application to the study of p53-modulated proteins secreted in lung cancer cells.

Chenau J, Michelland S, de Fraipont F, Josserand V, Coll JL, Favrot MC, Seve M. Chenau J, et al. Among authors: josserand v. J Proteome Res. 2009 Oct;8(10):4579-91. doi: 10.1021/pr900383g. J Proteome Res. 2009. PMID: 19639960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters